Note 2 - Selected Balance Sheet Data - Changes in Carrying Amount of Goodwill (Details) $ in Thousands |
6 Months Ended |
|---|---|
|
Dec. 31, 2016
USD ($)
| |
| Beginning balance | $ 430,882 |
| Acquisitions (Note 3) | 130,587 |
| Prior year acquisitions (Note 3) | 1,809 |
| Currency translation | (5,547) |
| Ending balance | 557,731 |
| Biotechnology [Member] | |
| Beginning balance | 105,181 |
| Acquisitions (Note 3) | 130,587 |
| Prior year acquisitions (Note 3) | |
| Currency translation | (2,580) |
| Ending balance | 233,188 |
| Diagnostics [Member] | |
| Beginning balance | 105,729 |
| Acquisitions (Note 3) | |
| Prior year acquisitions (Note 3) | |
| Currency translation | |
| Ending balance | 105,729 |
| Protein Platforms [Member] | |
| Beginning balance | 219,972 |
| Acquisitions (Note 3) | |
| Prior year acquisitions (Note 3) | 1,809 |
| Currency translation | (2,967) |
| Ending balance | $ 218,814 |
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|